Schedule of Investments (unaudited)	iShares® Evolved U.S. Healthcare Staples ETF
April 30, 2022	(Percentages shown are based on Net Assets)

Security	Shares		Value
Common Stocks
Biotechnology — 1.7%
Amgen Inc.		365	$	85,114
Bio-Rad Laboratories Inc., Class A(a)		190		97,291
Guardant Health Inc.(a)		892		55,036
Illumina Inc.(a)		1,215		360,430
Myriad Genetics Inc.(a)		874		17,917
NeoGenomics Inc.(a)		1,404		13,268
Veracyte Inc.(a)		665		13,613
				642,669
Commercial Services — 0.4%
AMN Healthcare Services Inc.(a)		476		46,529
Bright Horizons Family Solutions Inc.(a)		304		34,729
Grand Canyon Education Inc.(a)		287		27,543
Progyny Inc.(a)		498		19,148
R1 RCM Inc.(a)		928		20,899
Strategic Education Inc.		95		6,137
				154,985
Computers — 0.1%
Maximus Inc.		403		29,371
Cosmetics & Personal Care — 0.1%
Procter & Gamble Co. (The)		228		36,605
Electrical Components & Equipment — 0.1%
Novanta Inc.(a)		341		43,887
Electronics — 0.9%
Agilent Technologies Inc.		2,112		251,898
Fortive Corp.		1,758		101,085
OSI Systems Inc.(a)		81		6,407
				359,390
Environmental Control — 0.0%
Stericycle Inc.(a)		265		13,300
Food Service — 0.0%
Healthcare Services Group Inc.		683		11,673
Health Care - Products — 43.0%
10X Genomics Inc., Class A(a)		248		11,844
Abbott Laboratories		25,993		2,950,206
ABIOMED Inc.(a)		589		168,796
Adaptive Biotechnologies Corp.(a)		552		4,554
Align Technology Inc.(a)		402		116,544
AngioDynamics Inc.(a)		456		9,599
AtriCure Inc.(a)		456		23,680
Avanos Medical Inc.(a)		380		11,081
Avantor Inc.(a)		1,395		44,473
Axogen Inc.(a)		209		1,513
Baxter International Inc.		3,572		253,826
Bio-Techne Corp.		321		121,880
Boston Scientific Corp.(a)		19,857		836,178
Bruker Corp.		722		41,508
Cardiovascular Systems Inc.(a)(b)		399		7,461
CareDx Inc.(a)		515		15,677
Cooper Companies Inc. (The)		627		226,372
Cutera Inc.(a)		133		7,223
Danaher Corp.		6,635		1,666,248
DENTSPLY SIRONA Inc.		1,595		63,784
Edwards Lifesciences Corp.(a)		8,721		922,507
Envista Holdings Corp.(a)		1,080		42,790

Security	Shares		Value
Health Care - Products (continued)
Exact Sciences Corp.(a)		1,885	$	103,769
Glaukos Corp.(a)		266		12,579
Globus Medical Inc., Class A(a)(b)		1,121		74,233
Haemonetics Corp.(a)		456		23,106
Henry Schein Inc.(a)		1,364		110,620
Hologic Inc.(a)		2,828		203,588
ICU Medical Inc.(a)		190		40,658
IDEXX Laboratories Inc.(a)		757		325,873
Inari Medical Inc.(a)		344		27,761
Inspire Medical Systems Inc.(a)(b)		344		70,781
Insulet Corp.(a)		912		217,959
Integer Holdings Corp.(a)		285		21,423
Integra LifeSciences Holdings Corp.(a)		798		48,806
Intersect ENT Inc.(a)		209		5,720
Intuitive Surgical Inc.(a)		5,219		1,248,907
iRhythm Technologies Inc.(a)		358		44,166
LeMaitre Vascular Inc.		209		9,031
LivaNova PLC(a)		566		43,390
Masimo Corp.(a)		703		79,418
Medtronic PLC		18,528		1,933,582
Merit Medical Systems Inc.(a)		646		40,058
NanoString Technologies Inc.(a)		434		8,151
Natera Inc.(a)		987		34,663
Neogen Corp.(a)		342		9,029
Nevro Corp.(a)		304		18,754
Novocure Ltd.(a)		649		49,700
NuVasive Inc.(a)		684		35,185
Omnicell Inc.(a)		379		41,375
OraSure Technologies Inc.(a)		663		4,071
Ortho Clinical Diagnostics Holdings PLC(a)		950		16,730
Orthofix Medical Inc.(a)		227		7,037
Pacific Biosciences of California Inc.(a)		1,350		8,559
Patterson Companies Inc.		762		23,447
Penumbra Inc.(a)		535		92,320
PerkinElmer Inc.		895		131,216
Quanterix Corp.(a)		300		6,657
Quidel Corp.(a)		478		48,096
ResMed Inc.		1,880		375,944
Shockwave Medical Inc.(a)		424		64,079
Silk Road Medical Inc.(a)		341		11,952
STAAR Surgical Co.(a)		512		29,230
STERIS PLC		549		123,003
Stryker Corp.		4,654		1,122,824
Tandem Diabetes Care Inc.(a)		648		62,519
Teleflex Inc.		593		169,373
Thermo Fisher Scientific Inc.		2,633		1,455,838
Waters Corp.(a)		343		103,936
Zimmer Biomet Holdings Inc.		2,265		273,499
Zimvie Inc.(a)		226		5,085
				16,565,444
Health Care - Services — 29.1%
Acadia Healthcare Co. Inc.(a)		946		64,215
Addus HomeCare Corp.(a)		154		12,979
agilon health Inc.(a)(b)		2,006		35,647
Amedisys Inc.(a)		477		60,889
Anthem Inc.		2,691		1,350,694
Centene Corp.(a)		6,857		552,331
Charles River Laboratories International Inc.(a)		171		41,298
Chemed Corp.		134		65,846
Community Health Systems Inc.(a)		1,541		11,819

1

Schedule of Investments (unaudited) (continued)	iShares® Evolved U.S. Healthcare Staples ETF
April 30, 2022	(Percentages shown are based on Net Assets)

Security	Shares		Value
Health Care - Services (continued)
DaVita Inc.(a)		991	$	107,395
Encompass Health Corp.		1,555		107,031
Ensign Group Inc. (The)		325		26,107
Fulgent Genetics Inc.(a)		264		14,488
HCA Healthcare Inc.		3,269		701,364
Humana Inc.		1,522		676,620
ICON PLC(a)(b)		110		24,883
Invitae Corp.(a)		1,975		10,487
IQVIA Holdings Inc.(a)		1,255		273,577
Laboratory Corp. of America Holdings(a)		1,142		274,400
LHC Group Inc.(a)		400		66,340
MEDNAX Inc.(a)		1,275		23,613
Medpace Holdings Inc.(a)		135		18,032
ModivCare Inc.(a)		134		13,932
Molina Healthcare Inc.(a)		562		176,159
Oak Street Health Inc.(a)		1,541		27,877
OPKO Health Inc.(a)		3,823		10,322
Quest Diagnostics Inc.		1,618		216,553
Select Medical Holdings Corp.		1,672		37,804
Surgery Partners Inc.(a)		475		24,301
Syneos Health Inc., Class A(a)		228		16,665
Teladoc Health Inc.(a)		1,507		50,876
Tenet Healthcare Corp.(a)		1,387		100,571
U.S. Physical Therapy Inc.		228		23,660
UnitedHealth Group Inc.		11,613		5,905,791
Universal Health Services Inc., Class B		949		116,281
				11,240,847
Household Products & Wares — 0.3%
Church & Dwight Co. Inc.		1,081		105,462
Machinery — 0.1%
Enovis Corp.(a)(b)		208		13,493
Esab Corp.(a)		208		9,776
				23,269
Pharmaceuticals — 20.9%
AbbVie Inc.		8,434		1,238,786
AdaptHealth Corp.(a)		753		9,533
AmerisourceBergen Corp.		1,296		196,072
Bausch Health Companies Inc.(a)		1,062		20,189
Becton Dickinson and Co.		3,753		927,704
Cardinal Health Inc.		3,002		174,266
Cigna Corp.		2,908		717,636
Covetrus Inc.(a)		650		8,970
CVS Health Corp.		13,323		1,280,740
Dexcom Inc.(a)		1,234		504,188
Eli Lilly & Co.		231		67,482
Embecta Corp.(a)		750		22,822
Johnson & Johnson		10,319		1,862,167
McKesson Corp.		1,346		416,735
Merck & Co. Inc.		721		63,945
Option Care Health Inc.(a)		1,008		30,119
Owens & Minor Inc.		648		22,998
Perrigo Co. PLC		282		9,673
Pfizer Inc.		8,589		421,462

Security	Shares		Value
Pharmaceuticals (continued)
Premier Inc., Class A		1,404	$	50,839
Zoetis Inc.		149		26,410
				8,072,736
Real Estate Investment Trusts — 1.2%
Healthpeak Properties Inc.		1,461		47,935
Medical Properties Trust Inc.		4,389		80,714
National Health Investors Inc.		250		12,883
Omega Healthcare Investors Inc.		986		25,123
Physicians Realty Trust		1,558		26,704
Sabra Health Care REIT Inc.		1,520		17,754
Ventas Inc.		2,419		134,375
Welltower Inc.		1,338		121,504
				466,992
Retail — 0.5%
National Vision Holdings Inc.(a)		362		13,630
Walgreens Boots Alliance Inc.		4,068		172,483
				186,113
Software — 1.0%
Allscripts Healthcare Solutions Inc.(a)		1,324		27,354
Apollo Medical Holdings Inc.(a)		445		16,233
Cerner Corp.		2,601		243,558
Change Healthcare Inc.(a)		1,877		44,222
Evolent Health Inc., Class A(a)		984		27,080
Outset Medical Inc.(a)		498		17,370
Phreesia Inc.(a)		270		6,178
Tabula Rasa HealthCare Inc.(a)		190		640
				382,635
Total Common Stocks — 99.4%
(Cost: $33,514,330)				38,335,378
Short-Term Investments
Money Market Funds — 1.1%
BlackRock Cash Funds: Institutional, SL Agency Shares, 0.38%(c)(d)(e)		233,511		233,511
BlackRock Cash Funds: Treasury, SL Agency Shares, 0.34%(c)(d)		196,000		196,000
				429,511
Total Short-Term Investments — 1.1%
(Cost: $429,511)				429,511
Total Investments in Securities — 100.5%
(Cost: $33,943,841)				38,764,889
Other Assets, Less Liabilities — (0.5)%				(200,645	)
Net Assets — 100.0%			$	38,564,244

^(a) Non-income producing security.

^(b) All or a portion of this security is on loan.

^(c) Affiliate of the Fund.

^(d) Annualized 7-day yield as of period end.

^(e) All or a portion of this security was purchased with the cash collateral from loaned securities.

2

Schedule of Investments (unaudited) (continued)	iShares® Evolved U.S. Healthcare Staples ETF
April 30, 2022

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the period ended April 30, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliated Issuer	Value at 07/31/21		Purchases at Cost			Proceeds from Sales			Net Realized Gain (Loss)			Change in Unrealized Appreciation (Depreciation)			Value at 04/30/22		Shares Held at 04/30/22		Income			Capital Gain Distributions from Underlying Funds
BlackRock Cash Funds: Institutional, SL Agency Shares	$	175,635	$	58,052	(a)	$	—		$	(174	)	$	(2	)	$	233,511		233,511	$	172	(b)	$	—
BlackRock Cash Funds: Treasury, SL Agency Shares		1,006,000		—			(810,000	)(a)		—			—			196,000		196,000		120			—
									$	(174	)	$	(2	)	$	429,511			$	292		$	—

^(a) Represents net amount purchased (sold).

^(b) All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

• Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

• Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

• Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the BlackRock Global Valuation Methodologies Committee’s (the “Global Valuation Committee’s”) assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds. There may not be a secondary market, and/or there are a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Fund’s policy regarding valuation of financial instruments, refer to its most recent financial statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

	Level 1		Level 2		Level 3		Total
Investments
Assets
Common Stocks	$	38,335,378	$	—	$	—	$	38,335,378
Money Market Funds		429,511		—		—		429,511
	$	38,764,889	$	—	$	—	$	38,764,889

Portfolio Abbreviations - Equity
REIT	Real Estate Investment Trust

3